🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Removal

Based on TikTok, the platform has taken down problematic material and banned related hashtags and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

Within moments of entering one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these communities, messages display black plastic parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.